Stockreport

Nuvectis Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Nuvectis Pharma, Inc.  (NVCT) 
PDF Fort Lee, NJ, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused [Read more]